DELIVERING CURES FOR CANCER
We are dedicated to advancing universal cancer care by fast tracking the availability of curative treatments for all cancers, using cutting edge tumor targeting technologies and nano medicine delivery systems. Our mission is to save lives, improve the quality of life for cancer patients undergoing therapy, and ultimately to preserve families.
Add Your Heading Text Here
POST YOUR ART TODAY!
WE HAVE CREATED THE WORLD'S FIRST PUBLICLY UPLOADABLE ART GALLERY.
WE ARE LOOKING FOR ANYBODY ARTISTIC TO POST THEIR ART TODAY!
JOIN THE MOVEMENT TO
"STOMP OUT CANCER."
PAINT A PICTURE, DANCE, SING A SONG. WHATEVER COMES OUT GOOFY, SERIOUS, AWESOME WE DON'T CARE! CREATING SOMETHING IS THE WHOLE POINT. WE ARE STEPPING CLOSER AND CLOSER TO A CURE EVERYDAY. PUT THE ENERGY OF FINDING A CURE FOR EVERYONE WITH CANCER IN YOUR ART. TOGETHER WE CAN CREATE A MOVEMENT.
Get the latest updates on our research.
Delivering Cures for Cancer
4701 Randolph Rd.
Rockville MD 20852
*All donations are tax deductible.
OR DONATE ONLINE
support us and changethe future of cancer.
Drs. Ronald Shore and Joseph Fox, who founded Delivering Cures for Cancer and The Paula Shore/Sari Fox Foundation, receive no salary, income or other compensation from the Foundation. Their donations have covered the majority of the start up costs including website, legal, accounting, administrative, and promotions expenses. Dr. Shore, whose skin cancer screening program is described on this website, has helped to educate fellow dermatologists and other medical personnel on how to perform highly effective skin cancer screening through international lectures and publications, largely at personal expense. Honoraria for his presentations, if provided, have been returned to the institution (e.g. University of Pennsylvania), or given to charity (e.g. The Society for Dermatologic Physician Assistants). He receives no other compensation from industry, academic institutions or other entities. Dr. Shore has volunteered his time and knowledge on screening to 20/20 GeneSystems, Inc., the developer of the PAULAs Test, a new blood test for early detection of lung cancer. He has also served on its Medical Advisory Board. He has received no remuneration for these forms of assistance. Dr. Shore and Dr. Fox were each approached by 20/20 GeneSystems, Inc. to purchase shares to help the company continue its research, and both agreed to do so. Their investments in the company, in each case, represent well under 1% of total investments. Neither physician holds any controlling or voting position in the company, nor draws any salary or other compensation. Dr. Shore and Dr. Fox, who for several years have spoken to various individuals, organizations and government personnel to try to advance Dr. Esther Chang’s research, were each approached by SynerGeneTherape